Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%

MT Newswires Live

2024-09-11

Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%

Genetic Technologies (ASX:GTG) joined the Chicago-based CancerIQ platform, giving it access to the US healthcare system, according to a Wednesday filing with the Australian bourse.

As part of the move, Genetic Technologies will pay an annual fee of $75,000 to access CancerIQ's premium tier, the filing stated. This will give the molecular diagnostics company an entry point to over 45 health systems and 250 clinics in the US that are part of CancerIQ's platform.

The partnership includes the addition of Genetic Technologies' geneType risk assessment test portfolio to support CancerIQ's expansion into primary preventive care.

Genetic Technologies' shares were up nearly 8% in recent trade.

Price (AUD): $0.04, Change: $+0.0030, Percent Change: +7.50%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2466444609"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2466444609\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2466444609?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-11 10:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466444609","market":"sh","top_or_hot":-1,"title":"Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%","media":"MT Newswires Live","content":"<html><body><p>Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%</p><p> Genetic Technologies (ASX:GTG) joined the Chicago-based CancerIQ platform, giving it access to the US healthcare system, according to a Wednesday filing with the Australian bourse.</p><p>As part of the move, Genetic Technologies will pay an annual fee of $75,000 to access CancerIQ's premium tier, the filing stated. This will give the molecular diagnostics company an entry point to over 45 health systems and 250 clinics in the US that are part of CancerIQ's platform.</p><p>The partnership includes the addition of Genetic Technologies' geneType risk assessment test portfolio to support CancerIQ's expansion into primary preventive care.</p><p>Genetic Technologies' shares were up nearly 8% in recent trade.</p><p>Price (AUD): $0.04, Change: $+0.0030, Percent Change: +7.50%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%\n</h2>\n<h4 class=\"meta\">\n</h4><p class=\"head\">\n<strong class=\"h-name small\">MT Newswires Live</strong><span class=\"h-time small\">2024-09-11 10:54</span>\n</p>\n</header>\n<article>\n<p>Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8%</p><p> Genetic Technologies (ASX:GTG) joined the Chicago-based CancerIQ platform, giving it access to the US healthcare system, according to a Wednesday filing with the Australian bourse.</p><p>As part of the move, Genetic Technologies will pay an annual fee of $75,000 to access CancerIQ's premium tier, the filing stated. This will give the molecular diagnostics company an entry point to over 45 health systems and 250 clinics in the US that are part of CancerIQ's platform.</p><p>The partnership includes the addition of Genetic Technologies' geneType risk assessment test portfolio to support CancerIQ's expansion into primary preventive care.</p><p>Genetic Technologies' shares were up nearly 8% in recent trade.</p><p>Price (AUD): $0.04, Change: $+0.0030, Percent Change: +7.50%</p>\n<div class=\"bt-text\">\n<p> 來源：<a href=\"https://www.mtnewswires.com/\">MT Newswires Live</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"醫藥生物股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466444609","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466444609","pubTimestamp":1726023273,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8% Genetic Technologies (ASX:GTG) j","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","XJO.AU":"标普/澳交所 200指数","XKO.AU":"标普/澳交所 300指数","BK4125":"广播","XAO.AU":"标普/澳交所 普通股指数","BK7048":"生命科学工具和服务","BK4121":"生命科学工具和服务","GTG.AU":"Genetic Technologies Ltd"},"translate_title":"Genetic Technologies加入总部位于美国的CancerIQ平台；股价上涨8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AUD":1,"GENE":1,"GTG.AU":1,"XAO.AU":1,"XJO.AU":1,"XKO.AU":1},"content_text":"Genetic Technologies Joins US-Based CancerIQ Platform; Shares Up 8% Genetic Technologies (ASX:GTG) joined the Chicago-based CancerIQ platform, giving it access to the US healthcare system, according to a Wednesday filing with the Australian bourse.As part of the move, Genetic Technologies will pay an annual fee of $75,000 to access CancerIQ's premium tier, the filing stated. This will give the molecular diagnostics company an entry point to over 45 health systems and 250 clinics in the US that are part of CancerIQ's platform.The partnership includes the addition of Genetic Technologies' geneType risk assessment test portfolio to support CancerIQ's expansion into primary preventive care.Genetic Technologies' shares were up nearly 8% in recent trade.Price (AUD): $0.04, Change: $+0.0030, Percent Change: +7.50%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}